Effect of copper complexes on the development of adjuvant arthritis: Therapeutic and toxicological aspects

Biologia - Section Cellular and Molecular Biology

Volumn 60, Issue SUPPL. 17, 2005, Pages 65-68

  Bauerová, Katarína ^a   Valentová, Jindra ^b   Poništ, Silvester ^a   Navarová, Jana ^a   Komendová, Denisa ^a   Mihalová, Danica ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

Adjuvant arthritis; Copper complexes; Oxidative stress; Rats

Indexed keywords

ANIMALIA; MYCOBACTERIUM BUTYRICUM;

EID: 33751319639     PISSN: 13356399     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. BARRET, A.J. & HEATH, M.F. 1977. Lysosomal enzymes, pp. 19-147. In: DINGLE, J.T. (ed.) Lysosomes, a Laboratory Handbook, Elsevier/North-Holland Biomedical Press, Amsterdam.
2. BLAHOVÁ, M., SOKOLÍK, J., TUMOVÁ, I., LEPEJ, R. & ŠVEC, P. 2003. Anti-inflammatory activity of Aqua(Chlorophenoxya cetato)Copper(II) complexes. Acta Fac. Pharm. Univ. Comenianae 50: 24-29.
3. BROWN, R.K. & KELLY, F.J. 1996. Peroxides and other products, pp. 119-131. In: PUNCHARD, N.A & KELLY, F.J. (eds) Free Radicals, a Practical Approach, Oxford University Press, Oxford.
4. JURČOVIČOVÁ, J., ŠVÍK, K., ROVENSKÝ, J., STANČÍKOVÁ, M., ZORAD, S., KONEČNÁ, I., HOLEČEK, V. TREFIL, L., RACEK, J. & ROKYTA, R. 2000. Suppression of adjuvant arthritis in rats with chronic bromocriptine treatment does not prevent associated oxidative stress. Int. J. Immunopathol. Pharmacol. 13: 31-37.
5. LEVINE, R.L., GARLAND, D., OLIVER, C.N., AMICI, A., CLIMENT, I., LENZ, A.G., AHN, B.W., SHALTIEL, S. & STADTMAN, E.R. 1990. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186: 464-478.
6. LINDER, M.C. & HAZEGH-AZAM, M. 1996. Copper biochemistry and molecular biology. Am. J. Clin. Nutr. 63: 797S-811S.
7. LINDER, M.C., WOOTEN, L., CERVEZA, P., COTTON, S., SHULZE, R. & LOMELI, N. 1998. Copper transport. Am. J. Clin. Nutr. 67: 965S-971S.
8. MILNE, D.B. 1998. Copper intake and assessment of copper status. Am. J. Clin. Nutr. 67: 1041S-1045S.
9. MOTTA, C., GUEUX, E., MAZUR, A. & RAYSSIGUIER, Y. 1996. Lipid fluidity of triacylglycerol-rich lipoproteins isolated from copper-deficient rats. Br. J. Nutr. 75: 767-773.
10. MULTHAUP, G., HERMANN, H.D., BEYREUTHER, K. & BAYER, T.A. 2002. Role of copper and other transition metal ions in the pathogenesis of Parkinson's disease, prion diseases, familial amyotrophic lateral sclerosis, and Alzheimer's disease, pp. 297-317. In: MASSARO, E.J. (ed.) From Handbook of Copper Pharmacology and Toxicology, Humana Press Inc., Totowa, NJ.
11. PERCIVAL, S.S. 1998. Copper and immunity. Am. J. Clin. Nutr. 67: 1064S-1068S.
12. ŠTEFEK, M., TRNKOVÁ, Z. & KRIŽANOVÁ, L. 1999. 2,4-dinitrophenylhydrazine carbonyl assay in metal-catalysed protein glycoxidation. Redox Report 4: 43-48.
13. VALENTOVÁ, J., ŽEMLIČKA, M., VANIČKOVA, M. & LABUDA, J. 1997. SOD-mimic and radioprotective activity of N-salicylide neaminoalkanoatocopper(II) hydrates, pp. 251-256. In: ONDREJOVIČ, G. & SIROTA, A. (eds) Progress in Coordination and Organometallic Chemistry, Slovak Technical University Press, Bratislava.
14. WEDER, J.E., DILLON, C.T., HAMBLEY, T.W., KENNEDY, B.J., LAY, P.A., BIFFIN, J.R., REGTOP, H.L. & DAVIES, N.M. 2002. Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized. Chem. Rev. 232: 95-126.